Search - tctmd.com

Displaying 1 - 20 of 162

Sort: Relevancy | Date

Presentation TCT 2020

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Presenter: Hyo-Soo Kim

October 17, 2020

Presentation TCT 2020

My Top 5 Tips and Tricks for Successful Use of Physiologic Assessment in Bifurcation PCI

Presenter: Bon-Kwon Koo

October 17, 2020

Debate: What Should Be the Default Strategy for a True Left Main Bifurcation PCI? - Provisional Stenting Should Be the Gold Standard, and EBC-MAIN Will Prove It!

Presentation TCT 2020

Provisional Stenting Should Be the Gold Standard, and EBC-MAIN Will Prove It!

Presenter: David Hildick-Smith

October 17, 2020

Presentation TCT 2020

2020 Clinical Data Updates on Bifurcation PCI Techniques

Presenter: Gennaro Sardella

October 17, 2020

Presentation TCT 2020

Debate: What Should Be the Default Strategy for a True Left Main Bifurcation PCI? - DK-Crush Outperforms Both Provisional and Culotte Stenting!

Presenter: Emmanouil Brilakis

October 17, 2020

Presentation TCT 2020

TARGET FFR - Physiology-Guided Optimization of PCI: A Randomized Controlled Trial

Presenter: Damien Collison

October 16, 2020

Presentation TCT 2020

How to Use Intravascular Imaging to Optimize CTO PCI

Presenter: Robert Riley

October 16, 2020

Presentation TCT 2020

How to Use Intravascular Imaging to Optimize PCI in Severely Calcified Lesions

Presenter: Richard Shlofmitz

October 16, 2020

Presentation TCT 2020

Rationale and Techniques for Post-PCI Coronary Physiology Assessment

Presenter: Allen Jeremias

October 16, 2020

Presentation TCT 2020

Clopidogrel for Most!

Presenter: John Bittl

October 15, 2020

Presentation TCT 2020

TCT ID 3: Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention – Insights From REDUCE-IT PCI

Presenter: Benjamin Peterson

October 15, 2020

Presentation TCT 2020

1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial

Presenter: Manesh Patel

October 15, 2020

Presentation TCT 2020

ISCHEMIA in Perspective: Updated Meta-Analysis on PCI in SIHD

Presenter: Sripal Bangalore

October 15, 2020

Presentation TCT 2020

Yes! With the Right Training, Everyone Can (and Should) Do CTO PCI!

Presenter: Simon Walsh

October 15, 2020

Presentation TCT 2020

A Universal Nomenclature for CTO Terminology and Standardization of CTO PCI Trials: Introduction to CTO-ARC

Presenter: Luiz Ybarra

October 15, 2020

Presentation TCT 2020

Debate 2: Should CTO PCI Be Performed at Most Centers and by Most Operators? - No! CTO PCI Should Only Be Done by the Experts!

Presenter: Gerald Werner

October 15, 2020

Presentation TCT 2020

Robot-Assisted PCI as a Strategy to Reduce the Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses

Presenter: Pedro Lemos

October 14, 2020

Presentation TCT 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presenter: George Vlachojannis

October 14, 2020

Presentation TCT 2020

Case #2 Resolution

Presenter: Paul Teirstein

October 14, 2020

Presentation TCT 2020

The PROSPECT ABSORB Trial: Randomized Evaluation of Vulnerable Plaque Treatment with Percutaneous Coronary Intervention

Presenter: Gregg Stone

October 14, 2020

Advertisement

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

My Top 5 Tips and Tricks for Successful Use of Physiologic Assessment in Bifurcation PCI

Provisional Stenting Should Be the Gold Standard, and EBC-MAIN Will Prove It!

2020 Clinical Data Updates on Bifurcation PCI Techniques

Debate: What Should Be the Default Strategy for a True Left Main Bifurcation PCI? - DK-Crush Outperforms Both Provisional and Culotte Stenting!

TARGET FFR - Physiology-Guided Optimization of PCI: A Randomized Controlled Trial

How to Use Intravascular Imaging to Optimize CTO PCI

How to Use Intravascular Imaging to Optimize PCI in Severely Calcified Lesions

Rationale and Techniques for Post-PCI Coronary Physiology Assessment

Clopidogrel for Most!

TCT ID 3: Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention – Insights From REDUCE-IT PCI

1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial

ISCHEMIA in Perspective: Updated Meta-Analysis on PCI in SIHD

Yes! With the Right Training, Everyone Can (and Should) Do CTO PCI!

A Universal Nomenclature for CTO Terminology and Standardization of CTO PCI Trials: Introduction to CTO-ARC

Debate 2: Should CTO PCI Be Performed at Most Centers and by Most Operators? - No! CTO PCI Should Only Be Done by the Experts!

Robot-Assisted PCI as a Strategy to Reduce the Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Case #2 Resolution

The PROSPECT ABSORB Trial: Randomized Evaluation of Vulnerable Plaque Treatment with Percutaneous Coronary Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content